West Pharmaceutical Services (WST) Net Margin (2016 - 2025)
Historic Net Margin for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 17.14%.
- West Pharmaceutical Services' Net Margin fell 5500.0% to 17.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.88%, marking a year-over-year decrease of 9300.0%. This contributed to the annual value of 16.52% for FY2024, which is 30000.0% down from last year.
- Per West Pharmaceutical Services' latest filing, its Net Margin stood at 17.14% for Q3 2025, which was down 5500.0% from 16.54% recorded in Q2 2025.
- In the past 5 years, West Pharmaceutical Services' Net Margin registered a high of 24.7% during Q2 2021, and its lowest value of 12.38% during Q1 2025.
- Its 5-year average for Net Margin is 18.87%, with a median of 18.27% in 2023.
- Its Net Margin has fluctuated over the past 5 years, first soared by 99600bps in 2021, then plummeted by -70800bps in 2022.
- Over the past 5 years, West Pharmaceutical Services' Net Margin (Quarter) stood at 20.21% in 2021, then tumbled by -30bps to 14.08% in 2022, then rose by 30bps to 18.27% in 2023, then decreased by -6bps to 17.11% in 2024, then increased by 0bps to 17.14% in 2025.
- Its Net Margin stands at 17.14% for Q3 2025, versus 16.54% for Q2 2025 and 12.38% for Q1 2025.